METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/STAT3 signaling pathway

Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67:358–80.

Article  PubMed  Google Scholar 

Lee J, Kim JS, Cho HI, Jo SR, Jang YK. JIB-04, a Pan-inhibitor of histone demethylases, targets histone-lysine-demethylase-dependent AKT pathway, leading to cell cycle arrest and inhibition of cancer stem-like cell properties in hepatocellular carcinoma cells. Int J Mol Sci. 2022;23:7657.

Yao CY, Gao ZX, Hou LL, Fang D. DKK1 promotes NUAK1 transcriptional expression through the activation Akt in hepatocellular carcinoma. Cell Biol Int. 2022;47:383–93.

Kong H, Sun J, Zhang W, Zhang H, Li H. Long intergenic non-protein coding RNA 1273 confers sorafenib resistance in hepatocellular carcinoma via regulation of methyltransferase 3. Bioengineered. 2022;13:3108–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong HL, Ng LPW, Koh SP, Chan LWC, Wong EYK, Xue VW, et al. Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells. Oncotarget. 2018;9:20426–38.

Article  PubMed  PubMed Central  Google Scholar 

Mansour FA, Al-Mazrou A, Al-Mohanna F, Al-Alwan M, Ghebeh H. PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis. Oncoimmunology. 2020;9:1729299.

Article  PubMed  PubMed Central  Google Scholar 

Park S-R, Kim S-R, Hong I-S, Lee H-Y. A novel therapeutic approach for colorectal cancer stem cells: blocking the PI3K/Akt signaling axis with caffeic acid. Front Cell Dev Biol. 2020;8:585987.

Article  PubMed  PubMed Central  Google Scholar 

Chhabra R. let-7i-5p, miR-181a-2-3p and EGF/PI3K/SOX2 axis coordinate to maintain cancer stem cell population in cervical cancer. Sci Rep. 2018;8:1–9.

Article  CAS  Google Scholar 

Zhang L, Liang H, Zhang J, Yang Y, Ling X, Jiang H. Long non-coding RNA SNHG16 facilitates esophageal cancer cell proliferation and self-renewal through the microRNA-802/PTCH1 axis. Curr Med Chem. 2022;29:6084–99.

Article  CAS  PubMed  Google Scholar 

Chen W, Dong J, Haiech J, Kilhoffer MC, Zeniou M. Cancer stem cell quiescence and plasticity as major challenges in cancer therapy. Stem Cells Int. 2016;2016:1740936.

Article  PubMed  PubMed Central  Google Scholar 

Chen XY, Zhang J, Zhu JS. The role of m(6)A RNA methylation in human cancer. Mol Cancer. 2019;18:103.

Article  PubMed  PubMed Central  Google Scholar 

Lan Q, Liu PY, Haase J, Bell JL, Huttelmaier S, Liu T. The critical role of RNA m(6)A methylation in cancer. Cancer Res. 2019;79:1285–92.

Article  CAS  PubMed  Google Scholar 

Li H, Wang C, Lan L, Yan L, Li W, Evans I, et al. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability. Cell Mol Life Sci. 2022;79:1–22.

Article  Google Scholar 

Wang G, Dai Y, Li K, Cheng M, Xiong G, Wang X, et al. Deficiency of Mettl3 in bladder cancer stem cells inhibits bladder cancer progression and angiogenesis. Front Cell Dev Biol. 2021;9:627706.

Article  PubMed  PubMed Central  Google Scholar 

Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007;7:454–65.

Article  CAS  PubMed  Google Scholar 

Yang S, Wang B, Liu C, Wang Q, Wang R, Su W, et al. THAP9-AS1 promotes tumorigenesis and reduces ROS generation through the JAK2/STAT3 signaling pathway by increasing SOCS3 promoter methylation in osteosarcoma. Oxid Med Cell Longev. 2021;2021:5620475.

Article  PubMed  PubMed Central  Google Scholar 

Jiang L, Chen T, Xiong L, Xu JH, Gong AY, Dai B, et al. Knockdown of m6A methyltransferase METTL3 in gastric cancer cells results in suppression of cell proliferation. Oncol Lett. 2020;20:2191–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Zhou H, Han Y, Liu X, Wang M, Wang X, et al. SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer. J Mol Med. 2014;92:1257–69.

Article  CAS  PubMed  Google Scholar 

Chen H, Zhang C, Sheng Y, Yao S, Liu Z, Zhang C, et al. Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma. Am J Cancer Res. 2015;5:180.

PubMed  Google Scholar 

Jiang B-G, Wang N, Huang J, Yang Y, Sun L-L, Pan Z-Y, et al. Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients. Oncotarget. 2017;8:28621.

Article  PubMed  PubMed Central  Google Scholar 

Yang F, Zhang A. Involvement of METTL3 in arsenite-induced skin lesions by targeting the SOCS3/STAT3/Krt signaling pathway. Environ Pollut. 2023;316:120634.

Article  CAS  PubMed  Google Scholar 

Wu R, Liu Y, Zhao Y, Bi Z, Yao Y, Liu Q, et al. m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner. Cell Death Dis. 2019;10:1–15.

Google Scholar 

Wei X, You X, Zhang J, Zhou C. MicroRNA-1305 inhibits the stemness of LCSCs and tumorigenesis by repressing the UBE2T-dependent Akt-signaling pathway. Mol Ther Nucleic Acids. 2019;16:721–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang Q, Chen J, Di Z, Yuan W, Zhou Z, Liu Z, et al. TM4SF1 promotes EMT and cancer stemness via the Wnt/beta-catenin/SOX2 pathway in colorectal cancer. J Exp Clin Cancer Res. 2020;39:232.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lv Y, Lv X, Yang H, Qi X, Wang X, Li C, et al. LncRNA SNHG6/miR-125b-5p/BMPR1B axis: a new therapeutic target for triple-negative breast cancer. Front Oncol. 2021;11:678474.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu ZX, Li LM, Sun HL, Liu SM. Link between m6A modification and cancers. Front Bioeng Biotechnol. 2018;6:89.

Article  PubMed  PubMed Central  Google Scholar 

Xu H, Wang H, Zhao W, Fu S, Li Y, Ni W, et al. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma. Theranostics. 2020;10:5671–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dominguez E, Mauborgne A, Mallet J, Desclaux M, Pohl M. SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. J Neurosci. 2010;30:5754–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Q, Geng W, Guo H, Wang Z, Xu K, Chen C, et al. Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer. J Hematol Oncol. 2020;13:1–10.

Article  PubMed  PubMed Central  Google Scholar 

Gao Q, Zheng J, Ni Z, Sun P, Yang C, Cheng M, et al. The m6A methylation-regulated AFF4 promotes self-renewal of bladder cancer stem cells. Stem cells Int. 2020;2020:8849218.

Article  PubMed  PubMed Central  Google Scholar 

Yao QJ, Sang L, Lin M, Yin X, Dong W, Gong Y, et al. Mettl3-Mettl14 methyltransferase complex regulates the quiescence of adult hematopoietic stem cells. Cell Res. 2018;28:952–4.

Article  PubMed  PubMed Central  Google Scholar 

Iaiza A, Tito C, Ianniello Z, Ganci F, Laquintana V, Gallo E, et al. METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors. Clin Epigenet. 2021;13:173.

Article  CAS  Google Scholar 

Pan J, Liu F, Xiao X, Xu R, Dai L, Zhu M, et al. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis. J Exp Clin Cancer Res. 2022;41:19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie H, Li J, Ying Y, Yan H, Jin K, Ma X, et al. METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer. J Cell Mol Med. 2020;24:4092–104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Zhao H, Zheng L, Zhou Y, Wu L, Xu Y, et al. FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells. Theranostics. 2021;11:5045.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song RH, Du P, Gao CQ, Liu XR, Zhang JA. METTL3 is involved in the development of graves’ disease by inducing SOCS mRNA m6A modification. Front Endocrinol. 2021;12:666393.

Article  Google Scholar 

Zhang S, Ji WW, Wei W, Zhan LX, Huang X. Long noncoding RNA Meg3 sponges miR-708 to inhibit intestinal tumorigenesis via SOCS3-repressed cancer stem cells growth. Cell Death Dis. 2021;13:25.

Article  PubMed  PubMed Central  Google Scholar 

Chu J, Hu X-C, Li C-C, Li T-Y, Fan H-W, Jiang G-Q. KLF14 alleviated breast cancer invasion and M2 macrophages polarization through modulating SOCS3/RhoA/Rock/STAT3 signaling. Cell Signal. 2022;92:110242.

Article  CAS  PubMed 

留言 (0)

沒有登入
gif